Searched for
JUBILANT BIOSYS LTD
Karnataka attracted investment commitment of Rs 65,000 crore at WEF meet: Basavaraj BommaiKarnataka is at the forefront in attracting investments and the WEF Meet has proved to be a "success", he said, as he asserted that the Sta...- Jubilant Life signs $180 mn outlicensing deal with Checkpoint"The pact includes an upfront payment of $2 mn and contingent pre-clinical, clinical and regulatory payments including commercials up to $1...
- Investment in drug development firm to fetch Jubilant Life upto $22.6 millionJubilant Life Sciences today said its US arm stands to receive up to USD 22.6 million following the acquisition of a drug development firm.
- Jubilant Biosys signs drug discovery pact with Finland's Orion Corporation"The research deal is aimed at developing drug that can benefit large population with unmet needs in the pain management area," Jubilant sa...
- Jubilant Biosys expands drug discovery alliance with JanssenJubilant Biosys will carry out research services and deliver preclinical candidates to Janssen for potential development and commercialisat...
- India has huge human capital potential: N Chandrasekaran, TCSWhile India's short term concern is devaluation of rupee, slowing economic growth is a key concern for the long term, said Chandrasekaran.
- Jubilant Biosys announces filing of Investigational New DrugJubilant Biosys, a Bengaluru-based subsidiary of Jubilant Life Sciences, today announced the USFDA acceptance of The Investigational New Dr...
- Jubilant Biosys inks drug discovery pact with Mnemosyne PharmaJubilant Biosys today said it has entered into drug discovery collaboration with Mnemosyne Pharmaceutical Inc.
- US drugmaker Eli Lilly, Jubilant Life call off joint ventureUS drugmaker Eli Lilly & Company and Noida-based Jubilant Life Sciences have called off their equal drug-discovery partnership to develop m...
- Jubilant Biosys receives milestone payment from AstraZenecaEarlier this week Jubilant Biosys along with US-based Endo Pharmaceuticals received an undisclosed milestone payment for their joint progra...
- Global biotech firms seek partnerships in India for bigger gainsThe global biotechnology industry is moving towards strategic partnerships in a bid to create faster and cost-efficient means of drug disco...
- Jubilant extends collaboration with Eli LillyPharma company Jubilant Organosys has extended its four-year-old drug research collaboration with Eli Lilly for another five years.
- Jubilant Organosys ties up with US-based Endo PharmaceuticalsThe focus of the tie-up is to develop pre-clinical candidates for joint clinical development, a Jubilant Organosys release said.
- Jubilant Organosys up 11% on research dealShares of Jubilant Organosys were in demand on Tuesday after the pharmaceutical manufacturer signed a research deal with AstraZeneca for ne...
- Jubilant and Orion for joint manufacture of drugsBangalore-based Jubilant Biosys and Noida-based Jubilant Chemsys have together signed an agreement with Finnish pharmaceutical company Orio...
- Jubilant Biosys develops solution to accelerate drug discovery programmeJubilant Biosys, the Bangalore-based research subsidiary of Jubilant Organosys, has developed a screening solution to accelerate drug disco...
- Jubilant Organosys in drug discovery partnership with BioLeapJubilant Organosys has entered into a drug discovery partnership with US-based BioLeap, LLC.
- Jubilant ties up with ForestJubilant Organosys has entered into an agreement with US-based Forest Laboratories for discovery of drug candidates for a metabolic disorde...
- DRL on prowl overseas to scale up R&D optionsIndia’s largest drug maker, Dr Reddy’s Laboratories, is on the prowl for overseas acquisitions to scale up its custom pharmaceutical servic...
- Biocon in talks with Bayer for drug developmentTwo pharma cos may sign pact involving co-development of new biotech drugs & research services.
Load More
